v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Revenue        
Product sales, net $ 2,853,813 $ 3,186,596 $ 9,066,550 $ 8,973,726
Cost of products sold 1,044,540 1,517,561 3,320,411 3,675,552
Gross profit 1,809,273 1,669,035 5,746,139 5,298,174
Selling, general and administrative expenses 3,205,996 2,933,950 8,996,092 9,226,062
Research and development expenses 16,884 303,268 241,964 756,045
Total operating expenses 3,222,880 3,237,218 9,238,056 9,982,107
Loss from operations (1,413,607) (1,568,183) (3,491,917) (4,683,933)
Other (expenses) (1,046) (846) (3,278) (2,782)
Interest income 3,582 6,495
Loss before provision for income tax and equity in net earnings of equity investments (1,411,071) (1,569,029) (3,488,700) (4,686,715)
Provision for income tax (6,475) (16,522) (18,339) (80,147)
Loss before equity in net earnings of equity investments (1,417,546) (1,585,551) (3,507,039) (4,766,862)
Loss in equity investments (253,451) (28,941) (554,766)
Net Loss (1,417,546) (1,839,002) (3,535,980) (5,321,628)
Net loss attributable to noncontrolling interests (6,605) (137,752) (138,915) (1,113,958)
Net loss attributable to Milestone Scientific Inc. $ (1,410,941) $ (1,701,250) $ (3,397,065) $ (4,207,670)
Net loss per share applicable to common stockholders—        
Basic (in dollars per share) $ (0.04) $ (0.06) $ (0.10) $ (0.16)
Diluted (in dollars per share) $ (0.04) $ (0.06) $ (0.10) $ (0.16)
Weighted average shares outstanding and to be issued—        
Basic (in shares) 33,573,676 29,155,712 32,501,221 25,965,566
Diluted (in shares) 33,573,676 29,155,712 32,501,221 25,965,566
Milestone China [Member]        
Revenue        
Product sales, net $ 356,400   $ 712,800 $ 3,203,466
Loss in equity investments $ (253,451) $ 0 $ (554,766)

Source